We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
PROF

Price
6.35
Stock movement down
-0.04 (-0.86%)
Company name
Profound Medical Corp
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
138.24M
Ent value
122.29M
Price/Sales
15.39
Price/Book
4.45
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-1.99%
1 year return
-50.22%
3 year return
-13.99%
5 year return
-21.92%
10 year return
-
Last updated: 2025-09-15

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

PROF does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales15.39
Price to Book4.45
EV to Sales13.61

FINANCIALS

Per share

Loading...
Per share data
Current share count30.05M
EPS (TTM)-1.27
FCF per share (TTM)-1.01

Income statement

Loading...
Income statement data
Revenue (TTM)8.98M
Gross profit (TTM)5.57M
Operating income (TTM)-17.42M
Net income (TTM)-31.39M
EPS (TTM)-1.27
EPS (1y forward)-1.31

Margins

Loading...
Margins data
Gross margin (TTM)62.02%
Operating margin (TTM)-193.89%
Profit margin (TTM)-349.41%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash27.12M
Net receivables7.03M
Total current assets40.88M
Goodwill0.00
Intangible assets329.00K
Property, plant and equipment1.02M
Total assets42.23M
Accounts payable3.40M
Short/Current long term debt6.23M
Total current liabilities6.68M
Total liabilities11.17M
Shareholder's equity31.06M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-24.83M
Capital expenditures (TTM)2.00
Free cash flow (TTM)-24.99M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-101.05%
Return on Assets-74.32%
Return on Invested Capital-85.01%
Cash Return on Invested Capital-67.67%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.62
Daily high4.79
Daily low4.55
Daily Volume86K
All-time high28.09
1y analyst estimate12.10
Beta0.30
EPS (TTM)-1.27
Dividend per share-
Ex-div date-
Next earnings date30 Oct 2025

Downside potential

Loading...
Downside potential data
PROFS&P500
Current price drop from All-time high-83.62%-1.46%
Highest price drop-99.74%-56.47%
Date of highest drop19 Jul 20179 Mar 2009
Avg drop from high-50.78%-10.99%
Avg time to new high58 days12 days
Max time to new high1141 days1805 days
COMPANY DETAILS
PROF (Profound Medical Corp) company logo
Marketcap
138.24M
Marketcap category
Small-cap
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.
Employees
142
Investor relations
-
SEC filings
CEO
Arun S. Menawat
Country
USA
City
Mississauga
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...